|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 541.5 USD | -1.05% |
|
-5.75% | +2.02% |
| Apr. 17 | TD Cowen Raises Price Target on Thermo Fisher Scientific to $644 From $612 | MT |
| Apr. 17 | HSBC Adjusts Thermo Fisher Scientific Price Target to $660 From $630 | MT |
By Jaime Llinares Taboada
The U.K. Competition and Markets Authority said Friday that it has decided it won't refer Thermo Fisher Scientific Inc.'s planned $17.4 billion acquisition of pharmaceutical-testing company PPD Inc. to a phase 2 investigation.
The regulator had announced a probe into the deal in October, to see if it would lead to a lessening of competition.
Write to Jaime Llinares Taboada at jaime.llinares@wsj.com; @JaimeLlinaresT
(END) Dow Jones Newswires
12-03-21 0232ET
| 1st Jan change | Capi. | |
|---|---|---|
| +2.02% | 207B | |
| +2.17% | 175B | |
| +10.45% | 132B | |
| +16.62% | 99.1B | |
| -2.70% | 60.89B | |
| +13.38% | 52.04B | |
| -6.33% | 45.48B | |
| -4.74% | 38.81B | |
| +9.89% | 38.77B | |
| +3.25% | 26.09B |
THERMO FISHER SCIENTIFIC 
